Cancer BiologybioRxivPreprint
In silico engineered multitarget-directed ligands for the polypharmaceutical treatment of PTEN loss of function endometrial adenocarcinoma
Ritchie Delara, Vaidehi Mujumdar, Qi Zhang…·Donald L. Durden
The paper designs in silico multitarget-directed ligands for treating PTEN loss of function endometrial adenocarcinoma by exploiting synthetic lethality between PTEN LOF and CDK9 inhibition.
DOI 10.64898/2026.08.28.747865